Our finding of higher ZNF737 expression in association with lower bladder cancer risk is consistent with tumor suppressive activity previously documented for ZNF750 in esophageal squamous cell carcinoma33, ZNF24 in breast cancer34, and ZNF185 in prostate cancer35. This evidence concerns the gene ZNF750 and urinary bladder cancer.